MLHW (Japan) approves updated indication for Shingrix for the prevention of Shingles – GSK
GSK plc announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved an updated indication for Shingrix (Recombinant Zoster Vaccine, Adjuvanted – RZV) for the… read more.